Earlier this year, the Supreme Court held that the USPTO
Director has the discretion to review decisions rendered by PTAB
judges. United States v. Arthrex, 141 S. Ct. 1970
(2021). For the second time following that decision, the Acting
USPTO Director has granted review of a Final Written Decision by
the PTAB.
In Proppant Express Investments, LLC v. Oren
Technologies, LLC, IPR2018-00733, Paper No. 94, Oren
Technologies petitioned the Director for review of the PTAB's
final written decision determining that all claims of challenged
U.S. Patent No. 9,440,785 are unpatentable as obvious in light of
the prior art. Relying on Oren Techs., LLC v. Proppant
Express Invs LLC, No. 2019-1778, 2021 WL 3120819 (Fed. Cir.
2021), in which the Federal Circuit found that the Board's
failure to address the evidence of commercial success amounted to
legal error, Oren argued that the Board failed to properly weigh
the objective evidence of nonobviousness. Id. at
7-8.